Patents by Inventor Berit Edsberg

Berit Edsberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TESOFENSINE AND METOPROLOL FOR TREATMENT OF HYPERTENSION
    Publication number: 20190060301
    Abstract: The present invention relates to treatment of hypertension using a combination of tesofensine and metoprolol. The treatment is particularly well suited for the treatment of hypertensive obese subjects and hypertensive diabetic subjects.
    Type: Application
    Filed: December 30, 2016
    Publication date: February 28, 2019
    Applicant: Saniona A/S
    Inventors: Berit EDSBERG, Thomas Amos JACOBSEN
  • Treating diabetes melitus using insulin injections with less than daily injection frequency
    Patent number: 9603904
    Abstract: The present invention relates to an insulin derivative for the treatment of a condition or disease where administration of insulin will be of benefit, comprising administering, to a patient in need thereof, effective dosages of the insulin derivative, wherein said insulin derivative exhibits a prolonged profile of action and wherein said dosages are administered at intervals longer than 24 hours.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: March 28, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Thue Johansen, Birgitte Koch Michelsen, Berit Edsberg
  • TREATING DIABETES MELITUS USING INSULIN INJECTIONS WITH LESS THAN DAILY INJECTION FREQUENCY
    Publication number: 20110230402
    Abstract: The present invention relates to an insulin derivative for the treatment of a condition or disease where administration of insulin will be of benefit, comprising administering, to a patient in need thereof, effective dosages of the insulin derivative, wherein said insulin derivative exhibits a prolonged profile of action and wherein said dosages are administered at intervals longer than 24 hours.
    Type: Application
    Filed: October 29, 2009
    Publication date: September 22, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Thue Johansen, Birgitte Koch Michelsen, Berit Edsberg